The billionaire Neuralink executive is reportedly mulling an investment into a rival brain chip firm
Tech entrepreneur Elon Musk is considering an investment into Synchron, a brain chip developer which competes with his own similar company, Neuralink, according to Reuters.
Musk has reached out to Synchron’s founder and CEO Thomas Oxley in recent weeks to explore a possible venture, four people familiar with the discussions told the outlet, though noted that the talks are far from finalized and it is yet unclear whether a deal will be made.
Based in New York City, Synchron is several steps ahead of Neuralink in securing regulatory approval to test its brain implants in humans, receiving the green light from the Food and Drug Administration (FDA) last year. Before that, it conducted a separate round of human trials on four people in Australia, gleaning valuable data for future tests.
